Use of triacontanol in preparation of medicaments for treatment of cancers
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 4, 2011
Issued Date -
N/A
app pub date -
Sep 30, 2007
filing date -
Nov 23, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Use of triacontanol in preparation of human medicaments for treatment of cancers, especially liver cancer, intestinal cancer, and lung cancer. Triacontanol can be formulated into many formulations, such as oral tablets, capsules, drop pills, sustained-released formulation, injectable solution, injectable powder, suspension, and emulsion.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully